Beijing New Oriental Star Petrochemical Engineering Co Ltd (SHE:002755) — Market Cap & Net Worth
Market Cap & Net Worth: Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755)
Beijing New Oriental Star Petrochemical Engineering Co Ltd (SHE:002755) has a market capitalization of $1.54 Billion (CN¥10.51 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #7179 globally and #1542 in its home market, demonstrating a -2.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing New Oriental Star Petrochemical Engineering Co Ltd's stock price CN¥11.32 by its total outstanding shares 928160351 (928.16 Million). Also see total assets of Beijing New Oriental Star Petrochemical for a full breakdown of the balance sheet.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Market Cap History: 2015 to 2026
Beijing New Oriental Star Petrochemical Engineering Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $3.31 Billion to $1.54 Billion (-4.02% CAGR). Also see Beijing New Oriental Star Petrochemical cash flow conversion for how efficiently the company converts equity into cash flow.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing New Oriental Star Petrochemical Engineering Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Beijing New Oriental Star Petrochemical share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.97x
Beijing New Oriental Star Petrochemical Engineering Co Ltd's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.77x
Beijing New Oriental Star Petrochemical Engineering Co Ltd's market cap is 10.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.31 Billion | $3.01 Billion | $509.01 Million | 1.10x | 6.51x |
| 2016 | $3.06 Billion | $3.09 Billion | $629.98 Million | 0.99x | 4.86x |
| 2017 | $2.10 Billion | $3.40 Billion | $607.54 Million | 0.62x | 3.46x |
| 2018 | $1.68 Billion | $3.93 Billion | $670.07 Million | 0.43x | 2.51x |
| 2019 | $2.11 Billion | $4.52 Billion | $780.96 Million | 0.47x | 2.71x |
| 2020 | $1.73 Billion | $3.78 Billion | $721.63 Million | 0.46x | 2.40x |
| 2021 | $1.71 Billion | $3.11 Billion | $379.91 Million | 0.55x | 4.50x |
| 2022 | $1.08 Billion | $1.87 Billion | -$225.83 Million | 0.58x | N/A |
| 2023 | $1.47 Billion | $1.44 Billion | -$148.53 Million | 1.02x | N/A |
| 2024 | $1.73 Billion | $1.78 Billion | $160.29 Million | 0.97x | 10.77x |
Competitor Companies of 002755 by Market Capitalization
Companies near Beijing New Oriental Star Petrochemical Engineering Co Ltd in the global market cap rankings as of September 19, 2026. Review 002755 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Beijing New Oriental Star Petrochemical Engineering Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Beijing New Oriental Star Petrochemical Engineering Co Ltd's market cap moved from $3.31 Billion to $ 1.54 Billion, with a yearly change of -4.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.54 Billion | -30.68% |
| 2025 | CN¥2.22 Billion | +28.48% |
| 2024 | CN¥1.73 Billion | +17.47% |
| 2023 | CN¥1.47 Billion | +36.27% |
| 2022 | CN¥1.08 Billion | -36.98% |
| 2021 | CN¥1.71 Billion | -1.02% |
| 2020 | CN¥1.73 Billion | -18.19% |
| 2019 | CN¥2.11 Billion | +25.59% |
| 2018 | CN¥1.68 Billion | -20.03% |
| 2017 | CN¥2.10 Billion | -31.30% |
| 2016 | CN¥3.06 Billion | -7.54% |
| 2015 | CN¥3.31 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Beijing New Oriental Star Petrochemical Engineering Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Billion USD |
| MoneyControl | $1.54 Billion USD |
| MarketWatch | $1.54 Billion USD |
| marketcap.company | $1.54 Billion USD |
| Reuters | $1.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more